19 June 2013
Keywords: israel, omrixplanning, ipo, usa, omrix, biopharmaceuticals, expected
Article | 15 September 2000
Omrix Biopharmaceuticals of Israel is expected to initiate an initialpublic offering in the USA, once the latter's Food and Drug
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
© 2013 thepharmaletter.com